Ubp-M inhibitors represent a distinctive class of chemical compounds that specifically target and modulate the activity of the deubiquitinase enzyme known as ubiquitin-specific protease M (Ubp-M). Deubiquitinases, a subgroup of proteases, play a crucial role in regulating cellular processes by reversing ubiquitination, a post-translational modification wherein ubiquitin molecules are attached to proteins. The ubiquitin-proteasome system governs protein turnover and maintains cellular homeostasis by orchestrating the degradation of marked proteins. Ubp-M, identified as a member of the deubiquitinase family, is implicated in fine-tuning ubiquitin signaling pathways.
Ubp-M inhibitors are designed to selectively interfere with the enzymatic activity of Ubp-M, thereby modulating ubiquitin-dependent processes within the cell. Structurally, these inhibitors exhibit a targeted binding affinity to the catalytic site of Ubp-M, preventing its interaction with ubiquitin substrates. By obstructing Ubp-M's deubiquitinase function, these compounds may influence cellular signaling cascades, protein stability, and degradation pathways. As a consequence, the precise modulation of Ubp-M activity by inhibitors offers researchers a valuable tool to decipher the intricate regulatory networks governed by ubiquitin-mediated processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $67.00 $262.00 | 10 | |
Chelates calcium, thus can disrupt calcium-dependent ubiquitination processes where USP16 is involved. | ||||||
P22077 | 1247819-59-5 | sc-478536 | 10 mg | $162.00 | ||
Inhibits USP7 and USP47, potential compensatory effects on USP16 activity due to ubiquitin pathway overlap. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
Selective inhibitor of USP14, indirectly affecting USP16 through the ubiquitin-proteasome system. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Ubiquitin-activating enzyme inhibitor, indirectly influencing USP16's substrate availability. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $75.00 $184.00 $423.00 | 1 | |
Broad-spectrum deubiquitinase inhibitor, could alter USP16 activity by general pathway inhibition. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $51.00 | 3 | |
USP7/USP47 inhibitor, can affect USP16 indirectly due to pathway crosstalk. | ||||||
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $200.00 | 1 | |
Inhibits USP4, USP5, and USP8, and may influence USP16 indirectly through ubiquitin pathway modulation. | ||||||